Palatin Technologies
PTN
#9856
Rank
โ‚น3.97 B
Marketcap
โ‚น2,337
Share price
-8.18%
Change (1 day)
3,216.12%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -โ‚น0.4 Billion

According to Palatin Technologies's latest financial reports the company's current earnings are โ‚น8.84 Million. In 2024 the company made an earning of -โ‚น2.45 Billion, an increase over its 2023 earnings that were of -โ‚น2.95 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น0.4 Billion-83.86%
2024 -โ‚น2.45 Billion-16.9%
2023 -โ‚น2.95 Billion5.99%
2022 -โ‚น2.79 Billion-13.7%
2021 -โ‚น3.23 Billion33.25%
2020 -โ‚น2.42 Billion-172.11%
2019 โ‚น3.35 B2352.33%
2018 โ‚น0.13 B-94.13%
2017 โ‚น2.32 B-154.92%
2016 -โ‚น4.25 Billion3.67%
2015 -โ‚น4.1 Billion878%
2014 -โ‚น0.42 Billion-72.64%
2013 -โ‚น1.53 Billion-33.11%
2012 -โ‚น2.29 Billion77.71%
2011 -โ‚น1.29 Billion
2003 -โ‚น2.18 Billion29.93%
2002 -โ‚น1.68 Billion36.18%
2001 -โ‚น1.24 Billion
1999 -โ‚น1.03 Billion6.04%
1998 -โ‚น0.97 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-โ‚น1.1 Billion 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚น2.69 Billion 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น53.01 B-12,262.47%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚น4.59 B-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น6.07 B-1,492.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น10.7 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.945 T-675,709.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚น5.05 Billion 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.189 T-273,088.15%๐Ÿ‡ฌ๐Ÿ‡ง UK